Brug af filgrastim- mobiliserede perifere blodstamceller har vist sig at reducere graden og varigheden af trombocytopeni efter myelosuppressiv eller myeloablativ kemoterapi.
The use of filgrastim-mobilised PBPCs has been shown to reduce the depth and duration of thrombocytopenia following myelosuppressive or myeloablative chemotherapy.